Advertisement

Index by author

July 01, 2012; Volume 342,Issue 1

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Ochman, Alexander R.
1. You have access
  MLR-1023 Is a Potent and Selective Allosteric Activator of Lyn Kinase In Vitro That Improves Glucose Tolerance In Vivo
  Michael S. Saporito, Alexander R. Ochman, Christopher A. Lipinski, Jeffrey A. Handler and Andrew G. Reaume
  
  Journal of Pharmacology and Experimental Therapeutics July 2012, 342 (1) 15-22; DOI: https://doi.org/10.1124/jpet.112.192096
2. You have access
  The Lyn Kinase Activator MLR-1023 Is a Novel Insulin Receptor Potentiator that Elicits a Rapid-Onset and Durable Improvement in Glucose Homeostasis in Animal Models of Type 2 Diabetes
  Alexander R. Ochman, Christopher A. Lipinski, Jeffrey A. Handler, Andrew G. Reaume and Michael S. Saporito
  
  Journal of Pharmacology and Experimental Therapeutics July 2012, 342 (1) 23-32; DOI: https://doi.org/10.1124/jpet.112.192187